Artikel mit Open-Access-Mandaten - Ric PriceWeitere Informationen
Nicht verfügbar: 1
Parasitaemia and fever in uncomplicated Plasmodium vivax malaria: a systematic review and individual patient data meta-analysis
ES Groves, JA Simpson, P Edler, A Daher, AP Pasaribu, DB Pereira, ...
Mandate: Bill & Melinda Gates Foundation, National Health and Medical Research …
Verfügbar: 304
A Long Neglected World Malaria Map: Plasmodium vivax Endemicity in 2010
PW Gething, IRF Elyazar, CL Moyes, DL Smith, KE Battle, CA Guerra, ...
Public Library of Science 6 (9), e1814, 2012
Mandate: US National Institutes of Health
A novel multiple-stage antimalarial agent that inhibits protein synthesis
B Baragaña, I Hallyburton, MCS Lee, NR Norcross, R Grimaldi, TD Otto, ...
Nature 522 (7556), 315-320, 2015
Mandate: Bill & Melinda Gates Foundation, US National Institutes of Health, UK …
Global extent of chloroquine-resistant Plasmodium vivax: a systematic review and meta-analysis
RN Price, L Von Seidlein, N Valecha, F Nosten, JK Baird, NJ White
The Lancet infectious diseases 14 (10), 982-991, 2014
Mandate: Wellcome Trust
“Asymptomatic” malaria: a chronic and debilitating infection that should be treated
I Chen, SE Clarke, R Gosling, B Hamainza, G Killeen, A Magill, ...
PLoS medicine 13 (1), e1001942, 2016
Mandate: Bill & Melinda Gates Foundation, UK Medical Research Council, Wellcome Trust
Mapping the global endemicity and clinical burden of Plasmodium vivax, 2000–17: a spatial and temporal modelling study
KE Battle, TCD Lucas, M Nguyen, RE Howes, AK Nandi, KA Twohig, ...
The Lancet 394 (10195), 332-343, 2019
Mandate: Bill & Melinda Gates Foundation, UK Medical Research Council, Wellcome Trust
A research agenda for malaria eradication: vector control
malERA Consultative Group on Vector Control
PLoS medicine 8 (1), e1000401, 2011
Mandate: US National Institutes of Health
Changes in the treatment responses to artesunate-mefloquine on the northwestern border of Thailand during 13 years of continuous deployment
VI Carrara, J Zwang, EA Ashley, RN Price, K Stepniewska, M Barends, ...
PloS one 4 (2), e4551, 2009
Mandate: US National Institutes of Health
Polymorphisms in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance 1 genes: parasite risk factors that affect treatment outcomes for P …
M Venkatesan, NB Gadalla, K Stepniewska, P Dahal, C Nsanzabana, ...
The American journal of tropical medicine and hygiene 91 (4), 833, 2014
Mandate: US National Institutes of Health, Wellcome Trust
Genomic epidemiology of artemisinin resistant malaria
MalariaGEN Plasmodium falciparum Community Project
elife 5, e08714, 2016
Mandate: Bill & Melinda Gates Foundation, US National Institutes of Health, National …
Quinolone-3-diarylethers: a new class of antimalarial drug
A Nilsen, AN LaCrue, KL White, IP Forquer, RM Cross, J Marfurt, ...
Science translational medicine 5 (177), 177ra37-177ra37, 2013
Mandate: US National Institutes of Health
The anaemia of Plasmodium vivax malaria
NM Douglas, NM Anstey, PA Buffet, JR Poespoprodjo, TW Yeo, NJ White, ...
Malaria journal 11, 1-14, 2012
Mandate: National Health and Medical Research Council, Australia
Plasmodium malariae and P. ovale genomes provide insights into malaria parasite evolution
GG Rutledge, U Böhme, M Sanders, AJ Reid, JA Cotton, ...
Nature 542 (7639), 101-104, 2017
Mandate: National Health and Medical Research Council, Australia, UK Medical Research …
Plasmodium vivax in the era of the shrinking P. falciparum map
RN Price, RJ Commons, KE Battle, K Thriemer, K Mendis
Trends in parasitology 36 (6), 560-570, 2020
Mandate: National Health and Medical Research Council, Australia, Wellcome Trust
Genomic analysis of local variation and recent evolution in Plasmodium vivax
RD Pearson, R Amato, S Auburn, O Miotto, J Almagro-Garcia, ...
Nature genetics 48 (8), 959-964, 2016
Mandate: US National Institutes of Health, National Health and Medical Research …
Growing evidence of Plasmodium vivax across malaria-endemic Africa
KA Twohig, DA Pfeffer, JK Baird, RN Price, PA Zimmerman, SI Hay, ...
PLoS neglected tropical diseases 13 (1), e0007140, 2019
Mandate: Bill & Melinda Gates Foundation, US National Institutes of Health, Wellcome …
KAF156 is an antimalarial clinical candidate with potential for use in prophylaxis, treatment, and prevention of disease transmission
KL Kuhen, AK Chatterjee, M Rottmann, K Gagaring, R Borboa, ...
Antimicrobial agents and chemotherapy 58 (9), 5060-5067, 2014
Mandate: US National Institutes of Health, A*Star, Singapore, Wellcome Trust
Malaria eradication and elimination: views on how to translate a vision into reality
M Tanner, B Greenwood, CJM Whitty, EK Ansah, RN Price, AM Dondorp, ...
BMC medicine 13, 1-22, 2015
Mandate: Australian Research Council, National Health and Medical Research Council …
Pyrazoleamide compounds are potent antimalarials that target Na+ homeostasis in intraerythrocytic Plasmodium falciparum
AB Vaidya, JM Morrisey, Z Zhang, S Das, TM Daly, TD Otto, NJ Spillman, ...
Nature communications 5 (1), 5521, 2014
Mandate: US National Institutes of Health, National Health and Medical Research …
Major burden of severe anemia from non-falciparum malaria species in Southern Papua: a hospital-based surveillance study
NM Douglas, DA Lampah, E Kenangalem, JA Simpson, JR Poespoprodjo, ...
PLoS medicine 10 (12), e1001575, 2013
Mandate: National Health and Medical Research Council, Australia, Wellcome Trust
Angaben zur Publikation und Finanzierung werden automatisch von einem Computerprogramm ermittelt